ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
T-Cell Exhaustion in the Tumor Microenvironment: Subcellular Dysfunction, Pan-Cancer Characteristics, and Therapeutic Interventions.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Although immune checkpoint blockade (ICB) therapy has profoundly reshaped the landscape of oncology, T-cell exhaustion (Tex) remains a core challenge in immunotherapy for solid tumors. Current research predominantly focuses on signal transduction and epigenetic regulation, whereas the adaptive alterations and dysfunction of subcellular organelles within T cells under the stress of the tumor microenvironment (TME) have not been systematically elucidated. This review proposes that suborganellar dysfunction serves as a key functional link in the progression of Tex. We systematically explore the role of dysregulated organelle interaction networks in this exhaustion, including mitochondrial dynamics and metabolic perturbations, aberrant endoplasmic reticulum (ER) stress responses, and mechanical stress-induced nuclear damage, elucidating how these alterations form a self-sustaining vicious cycle. Furthermore, we summarize the heterogeneity and commonalities of T-cell subcellular dysfunction across various solid tumors, such as oxidative stress-mediated mitochondrial damage in lung cancer, aberrant lipid metabolism-induced ER stress in hepatocellular carcinoma, and the suppression of lysosomal function in highly glycolytic tumors. Finally, we review emerging interventional strategies targeting these organelle checkpoints, such as nanomaterial-based mitochondrial protection, delivery systems modulating ER homeostasis, and stimuli-responsive matrix regulation technologies, aiming to provide novel perspectives for enhancing the anti-tumor efficacy of T cells via subcellular engineering approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.